A Substudy of the IBCSG 24-02/ SOFT Trial to Investigate Estrogen Suppression for Patients Participating in Arms B and C of the IBCSG 24-02/ SOFT Trial

Trial Profile

A Substudy of the IBCSG 24-02/ SOFT Trial to Investigate Estrogen Suppression for Patients Participating in Arms B and C of the IBCSG 24-02/ SOFT Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Exemestane (Primary) ; Triptorelin (Primary) ; Tamoxifen
  • Indications Early breast cancer
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms SOFT-EST
  • Most Recent Events

    • 08 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
    • 08 Aug 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 24 Feb 2016 Planned End Date changed from 1 Jun 2015 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top